Sathanantham, V.; Alberio, L.; Bovet, C.; Fontana, P.; Gerber, B.; Graf, L.; Mendez, A.; Sauter, T.C.; Schmidt, A.; Studt, J.-D.;
et al. Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study. Life 2022, 12, 1027.
https://doi.org/10.3390/life12071027
AMA Style
Sathanantham V, Alberio L, Bovet C, Fontana P, Gerber B, Graf L, Mendez A, Sauter TC, Schmidt A, Studt J-D,
et al. Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study. Life. 2022; 12(7):1027.
https://doi.org/10.3390/life12071027
Chicago/Turabian Style
Sathanantham, Vepusha, Lorenzo Alberio, Cédric Bovet, Pierre Fontana, Bernhard Gerber, Lukas Graf, Adriana Mendez, Thomas C. Sauter, Adrian Schmidt, Jan-Dirk Studt,
and et al. 2022. "Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study" Life 12, no. 7: 1027.
https://doi.org/10.3390/life12071027
APA Style
Sathanantham, V., Alberio, L., Bovet, C., Fontana, P., Gerber, B., Graf, L., Mendez, A., Sauter, T. C., Schmidt, A., Studt, J. -D., Wuillemin, W. A., & Nagler, M.
(2022). Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study. Life, 12(7), 1027.
https://doi.org/10.3390/life12071027
